LegisTrack
Back to all bills
HR 1064119th CongressIn Committee

Stopping Overdoses of Fentanyl Analogues Act

Introduced: Feb 6, 2025
Standard Summary
Comprehensive overview in 1-2 paragraphs

This bill, titled the Stopping Overdoses of Fentanyl Analogues Act, would amend the Controlled Substances Act to add fentanyl-related substances to Schedule I. It defines fentanyl-related substances by specific structural modifications relative to fentanyl and includes salts, isomers, and salts of isomers. Once enacted, any material containing fentanyl-related substances would be scheduled I unless exempted or listed in another schedule. The bill also provides that a fentanyl-related substance shall be treated as an analogue of a specific fentanyl compound for purposes of penalties under the Controlled Substances Act and the Controlled Substances Import and Export Act, without requiring proof that it meets the usual definition of a controlled-substance analogue. The act would take effect one day after enactment. In short, the bill hardens the legal status of fentanyl-related substances by immediately placing them on Schedule I and expanding penalties, with a broad structural test for inclusion and penalties that do not rely on proving analogue status under existing definitions.

Key Points

  • 1The bill adds fentanyl-related substances to Schedule I of the Controlled Substances Act, covering any amount of such substances (including their salts, isomers, and salts of isomers) unless exempted or listed elsewhere.
  • 2Fentanyl-related substances are defined by specific structural modifications to fentanyl (five enumerated modification pathways related to rings, substitutions, and acyl groups).
  • 3A fentanyl-related substance would be treated as an analogue of the reference fentanyl compound for penalties under CSA and the Controlled Substances Import and Export Act, without needing to prove analogue status under the usual analogue definition.
  • 4Penalties would apply as if the substance were that fentanyl analogue, under the existing criminal-penalty framework.
  • 5Effective date: the act becomes law one day after enactment.

Impact Areas

Primary group/area affected: Individuals and organizations involved in manufacturing, distributing, or possessing fentanyl-related substances; federal and local law-enforcement and prosecutors; and researchers who work with Schedule I substances (who would face stricter regulatory barriers).Secondary group/area affected: Laboratories and researchers conducting legitimate pharmacological or medical research with fentanyl-related compounds, who may face additional regulatory hurdles and licensing requirements due to Schedule I placement.Additional impacts: Potential expansion of enforcement discretion and penalties for fentanyl analogues, possible ripple effects for import/export controls, and a broader legal framework to address new fentanyl-related chemicals that could emerge.
Generated by gpt-5-nano on Nov 1, 2025